For type 1 diabetespatients, daily insulin
injections are a lifelong commitment. But these patients may soon be able to better
manage their disease — with the help of a medication used to treat psoriasis. I’m
Shelby Cullinan with your latest health news. A new study from Indiana University found
that the medication alefacept decreased insulin requirements in patients newly diagnosed with
type 1 diabetes. This medication also helped preserve function in pancreatic beta cells
for up to two years. Beta cells secrete insulin (the hormone which regulates blood sugar).
A secondary benefit of alefacept was that patients who took it needed less insulin.
They were also less likely to develop severe low blood sugar, called hypoglycemia, — a
common complication of diabetes. Speak to your doctor about new treatments available.